Kirkland, Ellenoff Guide Biotech SPAC's $200M IPO
A blank-check company seeking to combine with a health care business that has the capacity to develop new drug therapies and technologies told regulators Thursday it plans to raise $200 million...To view the full article, register now.
Already a subscriber? Click here to view full article